Market Size in 2020 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 207.2 Billion | USD 390.1 Billion | 8.7% | 2020 |
The global Healthcare Contract Development and Manufacturing Organization Market size accrued earnings worth approximately 207.2 (USD Billion) in 2020 and is predicted to gain revenue of about 390.1 (USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028. The report offers an assessment and analysis of the Healthcare Contract Development and Manufacturing Organization Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).
Healthcare Contract Development and Manufacturing Organization provide a slew of services on a contractual basis ranging from drug production to new drug launches in the pharmaceutical sector. It assists firms in outsourcing required business operations that require external aid, as well as enhanced scalability of firms. The firm offers services such as formal stability, batch registration, commercial production, clinical trials, method development, and formulation & pre-formulation development. A key aim of healthcare contract development and manufacturing firms is to promote the end-to-end efficacy of business operations and provide seamless solutions to clients.
Expansion of healthcare contract development and manufacturing organization industry in the next seven years can be ascribed to a surge in outsourcing activities by pharmaceutical firms & high funding in research & development programs. In addition to this, medical devices are also contributing sizably towards the growth of healthcare contract development and manufacturing organization business. Apparently, the rise in end-to-end service providers offering value-added solutions for risk-sharing business models will upswing industry expansion. Industry participants are offering biotech & pharmaceutical solutions at cost-effective rates, saving time for customers.
Furthermore, the rise in medical equipment in developing economies and the surge in the number of firms focusing on research & development activities will drive market trends. The surge in the efficiency of CDMO firms is set to contribute lucratively toward market size. Escalating the need for enhancing quality assurance solutions will prop up the expansion of the healthcare contract development and manufacturing organization industry. New product launches are slated to influence the business space.
Report Attributes | Report Details |
---|---|
Report Name | Healthcare Contract Development and Manufacturing Organization Market Research Report |
Market Size in 2020 | USD 207.2 Billion |
Market Forecast in 2028 | USD 390.1 Billion |
Growth Rate | CAGR of 8.7% |
Number of Pages | 255 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | Covance Inc., Sanmina Corporation, Thermo Fisher Scientific Inc., Jabil Inc., Lonza Group Ltd., Siegfried Holding AG, Recipharm AB, Flex Ltd., IQVIA Holdings Inc., and Catalent Inc. |
Segments Covered | By Services, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Base Year | 2020 |
Historical Year | 2016 to 2020 |
Forecast Year | 2021 - 2028 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North American Market To Retain Dominant Status Over Forecast Timespan
Expansion of the regional market over the assessment period can be due to the easy availability of healthcare infrastructure facilities and availing of outsourcing services at lesser costs. In addition to this, the massive need for medical equipment will translate into regional market growth. Furthermore, a thriving pharmaceutical sector in countries such as the U.S. will contribute significantly towards regional market proceeds.
Key players influencing market growth and profiled in the report are
FrequentlyAsked Questions
Expansion of healthcare contract development and manufacturing organization industry in next seven years can be ascribed to surge in outsourcing activities by pharmaceutical firms & high funding in research & development programs.
According to Zion market research report, the global Healthcare Contract Development and Manufacturing Organization Market size accrued earnings worth approximately 207.2 (USD Billion) in 2020 and is predicted to gain revenue of about 390.1 (USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is subject to to easy availability of healthcare infrastructure facility and availing of outsourcing services at lesser costs.
The key market participants include Covance Inc., Sanmina Corporation, Thermo Fisher Scientific Inc., Jabil Inc., Lonza Group Ltd., Siegfried Holding AG, Recipharm AB, Flex Ltd., IQVIA Holdings Inc., and Catalent Inc.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed